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Caveolae are specialized domains present in the plasma
membrane (PM) of most mammalian cell types. They
function in signalling, membrane regulation, and endocy-
tosis. We found that the Eps-15 homology domain-contain-
ing protein 2 (EHD2, an ATPase) associated with the static
population of PM caveolae. Recruitment to the PM
involved ATP binding, interaction with anionic lipids,
and oligomerization into large complexes (60–75S) via
interaction of the EH domains with intrinsic NPF/KPF
motifs. Hydrolysis of ATP was essential for binding of
EHD2 complexes to caveolae. EHD2 was found to undergo
dynamic exchange at caveolae, a process that depended on
a functional ATPase cycle. Depletion of EHD2 by siRNA or
expression of a dominant-negative mutant dramatically
increased the fraction of mobile caveolar vesicles coming
from the PM. Overexpression of EHD2, in turn, caused
conﬁnement of cholera toxin B in caveolae. The conﬁning
role of EHD2 relied on its capacity to link caveolae to actin
ﬁlaments. Thus, EHD2 likely plays a key role in adjusting
the balance between PM functions of stationary caveolae
and the role of caveolae as vesicular carriers.
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Introduction
Caveolae are invaginations in the plasma membrane (PM) with
a lipid composition enriched in cholesterol and sphingolipids
and two major protein components, the caveolins and the
cavins. Caveolins are integral membrane proteins stably asso-
ciated with each other and cholesterol to form a protein-lipid
scaffold that provides the organizing principle of caveolae
(Sargiacomo et al, 1995; Parton and Simons, 2007; Hayer
et al, 2010a). Cavins form soluble complexes in the cytosol
that bind to the caveolin scaffolds in the PM, and by providing
an additional peripheral protein layer they stabilize caveolae
and deﬁne their morphology (Hill et al, 2008; Hansen et al,
2009; McMahon et al, 2009; Hansen and Nichols, 2010).
Most of the caveolae are immobile and serve as signalling
platforms and membrane reservoirs in the PM (Parton and
Simons, 2007; Sinha et al, 2011). Several studies have
suggested that they are associated with actin microﬁlaments
(Rothberg et al, 1992; Stahlhut and van Deurs, 2000; Richter
et al, 2008). Interactions between components of the
cytoskeleton and caveolae are likely to control dynamics of
caveolae (Stahlhut and van Deurs, 2000; Mundy et al, 2002;
Foti et al, 2007; Sverdlov et al, 2009). Caveolae can be
activated through external or internal stimuli to undergo
internalization and to carry cargo from the PM to early
endosomes (EEs) (Parton et al, 1994; Thomsen et al, 2002;
Botos et al, 2008; Lajoie and Nabi, 2010). The endocytic
process requires dynamin, local actin rearrangements, and
phosphorylation events (Oh et al, 1998; Mundy et al, 2002;
Pelkmans and Helenius, 2002; Pelkmans et al, 2005; Sverdlov
et al, 2007). It is not clear which cellular factors regulate the
balance between static caveolae and motile caveolar carriers.
In this paper, we focus on Eps-15 homology domain-con-
taining protein 2 (EHD2), an ATPase that binds to the PM. In
a proteomics study, Aboulaich et al (2004) detected EHD2 as
one of the numerous proteins present in preparations of
caveolae isolated from human adipocytes. More recently,
Hansen et al (2011) expressed EHD2 as a ﬂuorescent fusion
protein in HeLa cells and found that it colocalized with CAV1.
While EHD2 is structurally well characterized, the cellular
functions remain elusive. It belongs to a dynamin-related family
of proteins of which the three others members (EHD1, 3, and 4)
are involved in the regulation of endocytic transport at the level
of the endosomal recycling compartment (Naslavsky and
Caplan, 2011). These three play a role in receptor sorting and
recycling (Blume et al, 2007; George et al, 2007; Sharma et al,
2008). EHD2 shares its overall domain structure with the other
EHDs (Figure 1A), and has a central G domain, which binds
and slowly hydrolyses ATP (Lee et al, 2005; Daumke et al,
2007). It associates with the PM, forms homooligomers instead
of heterooligomers (George et al, 2007), and tubulates
liposomes in vitro by forming oligomers around them
(Daumke et al, 2007). The crystal structure of the EHD2
dimer shows the two G domains with ﬂanking helical
domains organized into a compact scissor-shape structure
with a curved surface as the site of interaction with lipids
(Figure 1A; Daumke et al,2 0 0 7 ) .E Hd o m a i n sa r el o c a t e do n
top of the G domains. They are proposed to mediate
homooligomerization by binding to intrinsic NPF motifs in
adjacent EHD2 dimers (Daumke et al,2 0 0 7 ) .
We address the assembly and functions of EHD2 using
biochemistry- and microscopy-based approaches. Our results
show a progressive series of events that lead to the formation
of EHD2 complexes, and the association of these complexes
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regulating caveolar dynamics. Our data provide evidence that
EHD2 conﬁnes caveolae to the PM by providing a link to actin
ﬁlaments.
Results
EHD2 is associated with caveolae
When ﬂuorescent EHD2 (EHD2–EGFP) and caveolin-1
(CAV1–mCherry) were co-expressed in CV1 or HeLa cells,
they colocalized within numerous small puncta in the PM
(Supplementary Figure S1A). Total-internal reﬂection ﬂuor-
escent microscopy (TIR-FM) allowed us to determine that
95% of CAV1–mCherry-positive spots in the PM contained
EHD2–EGFP (Supplementary Figure S1B). Fluorescent ver-
sions of cavin-1 and cavin-2 also colocalized with EHD2–
EGFP in spots, indicating that the spots were caveolae. The
EHD2 signal did not overlap with puncta containing ﬂuor-
escent clathrin light chain or ﬂotillin1/2 (Supplementary
Figure S1C and D). Moreover, using indirect immunoﬂuores-
cence, we found that endogenous EHD2 was also enriched in
cell surface spots positive for endogenous CAV1 and cavin-1
in HeLa, 3T3L1, and A549 cells (Figure 1B; Supplementary
Figure S2A). For the endogenous EHD2, we observed in
Figure 1 EHD2 is associated with plasma membrane caveolae. (A) Scissor-shape structure of the EHD2 dimer. The membrane interaction site
and domains of one EHD2 molecule are depicted (pdb entry 2QPD) (Daumke et al, 2007). (B) Confocal images of HeLa cells stained with anti-
EHD2 and anti-CAV1 or anti-EHD2 and anti-cavin-1 antibodies. Lower row shows enlargement of indicated regions in the merged images. Scale
bars 10mm. (C) Confocal image of MEF CAV1 /  cells transfected with EHD2–EGFP only or EHD2–EGFP and CAV1–mCherry for 6h.
Enlargement of indicated regions is shown. Scale bars 10mm. (D) Gallery of electron micrographs of CV1 cells expressing EHD2–EGFP and
CAV1–HA for 6h. Cells were ﬁxed, cryo-sectioned, and immunolabelled with anti-GFP (10nm gold, arrows) and anti-HA (5nm gold). Scale bar
100nm. (E) Distance of EHD2- and CAV1-gold particles from the PM in EM micrographs. Scatter dot plot shows 60 perpendicular measurements
towards the PM with a maximal distance of 300nm. Bars represent mean of distributions. (F) FRETefﬁciencies in bleached and non-bleached
regions of ﬁxed CV1 cells expressing the indicated plasmids using confocal microscopy and acceptor photobleaching. Graphs show mean FRET
efﬁciencies with 95% conﬁdence intervals. n¼19, 8, 9, and 10 cells for EHD2–EGFP/CAV1–mCherry, EHD2–EGFP/CAV1–HA, EHD2–EGFP/
Flot1,2–mCherry, and CAV1–EGFP/CAV1–mCherry, respectively. Signiﬁcance of mean differences between bleached and non-bleached regions
was calculated with a two-tailed paired t-test. ***P-valueo0.0001, n.s.: not signiﬁcant.
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that there was a pool of free EHD2.
In mouse embryonic ﬁbroblasts (MEFs) devoid of CAV1
(CAV1 / ), ectopically expressed EHD2 was diffusely
distributed in the cytosol and PM. Expression of CAV1 in
such cells has been shown to drive caveolae formation (Fra
et al, 1995). When CAV1 was expressed in the CAV / 
MEFs, we rescued the localization of EHD2 in PM spots
(Figure 1C). This indicated that the presence of CAV1
was sufﬁcient to induce efﬁcient accumulation of EHD2 in
PM puncta.
To visualize the distribution of EHD2 and CAV1 by electron
microscopy (EM), we immunogold labelled cryo-sections
from CV1 cells expressing EHD2–EGFP and CAV1–HA with
anti-GFP and anti-HA antibodies and 10 or 5nm gold parti-
cles, respectively. Invaginated caveolar structures in the PM
were observed and many of them were positive for both CAV1
and EHD2 (Figure 1D). Of the EHD2 gold particles in proxi-
mity to CAV1, 92% were localized at invaginated caveolae
and caveolar clusters. In contrast to CAV1, gold-labelled
EHD2 was not evenly distributed over the entire caveolar
invagination but rather localized closer to the rim as
quantiﬁed in Figure 1E.
We concluded that EHD2 associated with the majority of
caveolae in the PM. The association involved indented ca-
veolae and caveolar clusters. When the cellular localization
of the three other EHD family members was analysed by
confocal microscopy, ﬂuorescent forms of EHD1 and EHD3
were not detected in caveolae but in vesicular and tubular
structures. EHD4, the closest homologue of EHD2, was
present in 10% of CAV1-positive spots (Supplementary
Figure S2B).
EHD2 molecules are in close proximity to CAV1
Immunoprecipitation with antibodies against CAV1 and
cavin-1 failed to bring down detectable amounts of EHD2
and vice versa, suggesting that EHD2 molecules did not
interact strongly with these caveolar proteins (not shown).
To examine whether EHD2 was in close proximity to CAV1,
ﬂuorescence resonance energy transfer (FRET) was mea-
sured. We analysed the effect of acceptor (X-mCherry) photo-
bleaching on the ﬂuorescence intensity of donor (Y-EGFP)
molecules in ﬁxed CV1 cells (see Materials and methods).
FRET efﬁciencies were quantiﬁed in individual PM puncta
within bleached versus non-bleached regions of cells
(Figure 1F).
The average FRET efﬁciency between EHD2–EGFP and
CAV1–mCherry in puncta located in bleached regions was
16%. This was signiﬁcantly higher than in non-bleached
regions (Figure 1F). No difference in FRET efﬁciencies of
bleached versus non-bleached regions was detected when
EHD2–EGFP was co-expressed with ﬂotillin1/2–mCherry or
in our negative control (EHD2–EGFP, CAV1–HA). In cells co-
expressing CAV1–EGFP and CAV1–mCherry, the measured
FRET efﬁciency was 48%, i.e., consistent with tightly knit
CAV1 homooligomers (Figure 1F; Sargiacomo et al, 1995).
Thus, EHD2 and CAV1 molecules in caveolae were close to
each other but probably not interacting directly.
EHD2 regulates caveolar motility
What could be the functional role of EHD2 associated with
caveolae? To address this question, we used RNA interference
to deplete cellular EHD2 in HeLa cells. After depletion of over
90% of EHD2 (Figure 2A), CAV1 was still detectable in
spots and the oligomeric state of CAV1 was not altered as
determined by sucrose velocity gradient centrifugation
(Supplementary Figure S3A and B). Both assays had been
used earlier to reveal the role of cavin-1 in the maintenance of
stable caveolar domains (Hayer et al, 2010b). Thus, EHD2 did
not seem to be required for caveolar formation and stability.
Strikingly, when live cells stably expressing CAV1–EGFP at
low levels were imaged (Supplementary Figure S3C), a dra-
matic change in caveolar dynamics was observed after EHD2
depletion (Supplementary Movie S1). A signiﬁcantly greater
number of CAV1 spots were now moving rapidly through the
cytoplasm in all directions. To quantify the increase in
motility, we bleached CAV1–EGFP in a peripheral region of
the cell and measured ﬂuorescence recovery over time by
confocal microscopy (see Materials and methods;
Supplementary Movies S2 and S3). In cells transfected with
non-targeting control siRNAs, recovery of signal in the
bleached volume was slow in agreement with previous
studies on caveolar motility (Thomsen et al, 2002; Tagawa
et al, 2005). This indicated that in our stable cell line, CAV1–
EGFP spots represented assembled caveolae. After 12min,
34% of the initial intensity had recovered (Figure 2B).
After depletion of EHD2, we measured a signiﬁcantly
increased recovery of 75 and 70% of CAV1–EGFP signal
using two different siRNA oligonucleotides (Figure 2B and
C; Supplementary Movie S3). When EHD2–mCherry was
expressed in EHD2-depleted cells, the original phenotype
with mainly stationary caveolae could be rescued and
CAV1–EGFP recovered only to 27% (Figure 2C).
Next, we studied the effect of EHD2 depletion on the
motility of cavin-1, which binds to caveolar domains after
these have arrived at the PM form the Golgi complex (Hill
et al, 2008; Hayer et al, 2010a). Cavin-1 does not bind to
unassembled CAV1 or to CAV1 in passage through the
secretory pathway (Hill et al, 2008). However, cavin-1 can
be detected in mobile caveolar vesicles (Boucrot et al, 2011),
and it follows CAV1 from the PM to EEs (Hayer et al, 2010b).
In a cell line stably expressing cavin-1–EGFP (Supplementary
Figure S3C), we detected signiﬁcantly more movement of
cavin-1–EGFP vesicles after EHD2 silencing than in control
cells treated with non-targeting siRNA (Figure 2D). As the
motility of both CAV1 and cavin-1 was signiﬁcantly
increased, we concluded that the mobile vesicles were most
likely derived from the PM.
Budding of caveolae from the PM requires dynamin
(Henley et al, 1998; Oh et al, 1998). We expressed the
dominant-negative dynamin-K44A mutant in cells treated
with EHD2 siRNA. Strikingly, the extent of CAV1 movement
was now signiﬁcantly decreased in comparison with control
cells (Figure 2E). This was consistent with the mobile caveo-
lar vesicles being derived from the PM and with a role of
EHD2 in restraining caveolae to the PM.
EHD2-positive caveolae conﬁne cholera toxin to the PM
The uptake of cholera toxin (CT) into mammalian cells can
be mediated by several endocytic mechanisms (Kirkham
et al, 2005; Chinnapen et al, 2007). The role of caveolae
has been intensively studied as they are enriched in the
ganglisode GM1, to which the B subunits of CT (CT-B) bind
(Parton, 1994; Chinnapen et al, 2007). We investigated the
EHD2 conﬁnes caveolae to the plasma membrane
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of CV1 cells with a very low concentration of ﬂuorescently
labelled CT-B for 30min followed by a 30-min chase (see
Materials and methods), the majority of CT-B was found in
giantin-positive Golgi structures (Figure 3A). However when
EHD2 was overexpressed, there was a signiﬁcant reduction of
CT-B signal in the Golgi area (Figure 3A and B). Now the PM
contained many CT-B-positive spots that colocalized with
EHD2 (Figure 3C). In time-lapse movies, we found that the
observed EHD2- and CT-B-positive spots at the PM were static
(not shown). All the puncta were also positive for endogen-
ous CAV1 showing that clustering of CT-B occurred in PM
caveolae (Figure 3D).
The localization of CT-B in caveolae even after long in-
cubation periods has been reported previously (van Deurs
et al, 2003). To test whether EHD2 inﬂuenced trapping of CT-
B by caveolae, we quantiﬁed the percentage of caveolae that
colocalized with CT-B in cells overexpressing EHD2 and
control cells. Strikingly, nearly 100% of caveolae positive
for both endogenous CAV1 and ﬂuorescent EHD2 contained
CT-B (Figure 3E). In control cells, only 50% of caveolae were
positive for CT-B. We concluded that elevated levels of EHD2
impaired proper trafﬁcking of CT-B to the Golgi apparatus by
conﬁning CT-B to stationary caveolae at the PM.
EHD2 is limited to stationary caveolae in the PM where
it cycles on and off
In TIR-FM time-lapse movies of CV1 cells expressing
CAV1–mCherry and EHD2–EGFP, we could easily distinguish
stationary and mobile CAV1 puncta. A merge of both chan-
nels revealed nearly 100% overlap of CAV1–mCherry and
EHD2–EGFP signal in caveolae that did not move during the
4-min movie (Supplementary Movie S4). In contrast, CAV1
spots that were mobile were not enriched in EHD2
(Figure 4A; Supplementary Movie S4). That EHD2 was only
detected in stationary caveolae raised the possibility that,
unlike the cavins, EHD2 proteins were removed during or
shortly after caveolae detachment from the PM.
We have previously shown that caveolar domains are not
only present in the PM but also associated with EEs where
they contain cavin-1 (Pelkmans et al, 2004; Hayer et al,
2010b). When we transiently overexpressed CAV1–HA to
enhance CAV1 trafﬁcking to EE (Hayer et al, 2010b), we
could readily detect endogenous cavin-1 in Rab5-positive
Figure 2 EHD2 regulates motility of caveolae. (A) HeLa cells were transfected with siRNA targeting EHD2 or non-targeting siRNA (siRNA
control) and cell lysates were analysed after 72h by SDS–PAGE/western blot using the indicated antibodies. (B) Large regions in the cell
periphery of HeLa cells, stably expressing CAV1–EGFP, were bleached and the movement of CAV1–EGFP back into the bleached region
monitored through ﬂuorescence recovery. Intensities before and directly after bleaching (t¼0) were normalized to 100 and 0%. Cells were
imaged every 20s for 12min. Recovery curves for cells treated with siRNA control (n¼12) or EHD2 siRNA (n¼19) are presented. Data points
present mean values±s.e.m. (C) Relative CAV1 ﬂuorescence 12min after bleaching in cells transfected with siRNA control (n¼12), EHD2
siRNA oligo1 (n¼12) or oligo2 (n¼7) or after EHD2 silencing and transfection with EHD2–mCherry rescue (n¼10). (D) Relative cavin-1–
EGFP signal 12min after bleaching in HeLa cells, stably expressing cavin-1–EGFP, transfected with siRNA control (n¼9) or EHD2 siRNA
(n¼7). (E) Relative CAV1 ﬂuorescence 8min after bleaching in HeLa cells transfected with EHD2 siRNA (n¼12) or after EHD2 silencing and
transfection with dyn-K44A-RFP (n¼6). All bars represent mean±s.e.m. Signiﬁcance of mean differences between the conditions was
analysed with a two-tailed unpaired t-test. ***P-valueso0.0001.
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colocalized in PM spots, we did not observe endogenous
EHD2 associated with endosomes (Figure 4B). Thus unlike
cavin proteins, EHD2 did not trafﬁc with caveolae to EE.
To investigate the dynamics of EHD2 binding to PM
caveolae, we used ﬂuorescence recovery after photobleaching
(FRAP) and compared recovery rates of bleached, EGFP-
tagged EHD2, cavin-1, cavin-2 at static caveolae
(Figure 4C–E). Cavin-1 and cavin-2 recovered slowly
(o20% in 12min), and did not reappear in caveolar puncta.
This showed that cavin-1 and cavin-2 in caveolae did not
exchange with the free pool consistent with previous sugges-
tions (Hill et al, 2008; Hayer et al, 2010a). In contrast, EHD2–
EGFP recovered to 80% of the initial signal intensity in the
photobleached area during the 12-min acquisition time
(Figure 4D and E). Caveolar EHD2 underwent dynamic
exchange with a half-life of 2–4min. Since the EHD2 signal
reappeared precisely in the initially bleached spots positive
for CAV1, the turnover occurred at stationary caveolae
(Figure 4E). We concluded that EHD2–EGFP molecules
associated with static caveolae underwent continuous cycles
of association and dissociation.
Multiple domains are required for targeting EHD2 to
caveolae
To gain insights into the mode of association with caveolae,
we determined the cellular distribution of a panel of EHD2
mutants after expression in CV1 cells (Figure 5A). EGFP
fusions of the mutant proteins were transiently expressed
in cells for 6–8h and endogenous CAV1 was stained.
Representative confocal microscopy images with the focus
on the PM are shown in Figure 5B.
A point mutation in the lipid-binding motif (K327D) was
found to block association with caveolae; the mutant protein
localized to the cytosol and the nucleus. Mutations in the KPF
and NPF motif (KPF/NPF) and deletion of the EH domain
Figure 3 EHD2-positive caveolae conﬁne cholera toxin B to the plasma membrane. (A) CV1 cells expressing EHD2–mCherry were incubated
with ﬂuorescent CT-B-488 for 30min and chased for 30min. Cells were immunostained with anti-Giantin antibodies and analysed by confocal
microscopy; the focus was set to the Golgi apparatus. Marked cells express EHD2–mCherry and show decreased CT-B signal in Golgi area. Scale
bar 50mm. (B) Quantiﬁcation of the mean CT-B-488 ﬂuorescence in the Golgi region deﬁned by anti-Giantin staining of non-transfected control
cells and EHD2–mCherry-transfected cells. Scatter dot plots show all data points and the mean±s.e.m. (C) CV1 cells expressing EHD2–
mCherry were incubated with CT-B-488 as in (A). Confocal image with the focus on the plasma membrane is shown; the insets highlight
colocalization of CT-B and EHD2 in puncta. Scale bar 10mm. (D) Cells (as in B) were stained for endogenous CAV1. Arrows in the magniﬁcation
highlight colocalization of CT-B, EHD2, and CAV1. Scale bar 10mm. (E) Quantiﬁcation of caveolae colocalizing with CT-B after 30min
incubation and 30min chase (as in A). Cells were stained for endogenous CAV1 and imaged with focus on the plasma membrane by confocal
microscopy. In non-transfected cells, CAV1-positive spots were analysed. In EHD2-transfected cells, CAV1 and EHD2–mCherry-positive spots
were analysed. Ten cells were analysed for each condition. Bars represent mean±s.e.m. Signiﬁcance was analysed with a two-tailed unpaired
t-test. ***P-valueo0.0001.
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EHD2 was diffusely distributed over the PM.
In previous in-vitro assays, three G domain mutants were
shown to be defective or altered in their interactions with
ATP: EHD2-T72A was deﬁcient in ATP binding, EHD2-T94A
in ATPase activity, and EHD2-I157Q exhibited a signiﬁcantly
elevated ATP hydrolysis rate (Daumke et al, 2007). When
expressed in CV1 cells, neither EHD2-T72A nor EHD2-T94A
localized to caveolae. They had a diffuse cytosolic and/or
membrane-associated distribution. EHD2-I157Q, however,
showed a striking punctate distribution colocalizing with
endogenous CAV1 in the PM (Figure 5B).
After prolonged expression of all EHD2 mutant constructs
(416h), we frequently observed the formation of ﬁlopodia in
agreement with previous reports (Guilherme et al, 2004) and
found accumulation of EHD2 in the nucleus.
While the EHD2 mutants that did not colocalize with
caveolae did not affect CAV1 distribution in ﬁxed cells, we
noticed that expression of EHD2-I157Q or wild-type EHD2 for
416h altered the appearance of the immunostained CAV1.
The signal intensity of CAV1 per diffraction-limited caveolar
spot was signiﬁcantly increased in the EHD2 overexpressing
cells (Supplementary Figure S4A–C). Given that individual
caveolae contain a deﬁned number of CAV1 molecules
Figure 4 EHD2 is limited to stationary caveolae in the plasma membrane and undergoes dynamic exchange. (A) TIRF images (10s intervals) of
a time-lapse series of a CV1 cell, co-expressing EHD2–EGFPand CAV1–mCherry. Right panel: Maximum intensity projection of all frames of the
4-min movie with a frame rate of 0.5Hz. Arrows highlight moving caveolae devoid of EHD2. Scale bar 10mm. (B) Confocal image of a HeLa cell
expressing CAV1–HA and Rab5-RFP for 16h, immunostained for CAV1 and endogenous EHD2. Highlighted areas are enlarged and show EE or
PM regions. Arrows point to EE or PM spots. (C) Representative confocal images of FRAP experiments with cavin-1–EGFP or cavin-2–EGFP
expressing cells. No ﬂuorescence recovery can be detected during the recorded time. Scale bars 10mm. (D) FRAP curves of transfected CV1
cells. Relative EGFP intensity of indicated fusion proteins in bleached regions. Intensities before and directly after bleaching (t¼0) were set to
100 and 0%, respectively. Images were recorded every 20s for 12min. n¼10, 9, and 6 for EHD2–EGFP, cavin-1–EGFP, and cavin-2–EGFP,
respectively. (E) Representative confocal images of FRAP experiments with EHD2–EGFP expressing cells. EHD2–EGFP signal reappears at
initially bleached spots. Right panels: Spots are positive for co-expressed CAV1–mCherry. Scale bar 10mm.
EHD2 conﬁnes caveolae to the plasma membrane
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assumption that EHD2 association does not alter the
accessibility of CAV1 epitopes, our results indicated that
elevated cellular levels of wild-type EHD2 and EHD2-I157Q
enhanced the formation of clusters of multiple caveolae.
Taken together, the results showed that several domains in
EHD2 were required for targeting the protein to the PM and to
caveolae; the lipid-binding residues that allow association
with negatively charged phospholipids (Daumke et al, 2007),
the protein interaction and/or oligomerization domains, and
the ATPase-containing G domain. A functional ATP binding
and hydrolysis cycle was apparently essential for enrichment
in caveolae.
Association with caveolae requires EHD2
oligomerization
Based on the topology of domains revealed by the crystal
structure and in-vitro assays, it has been proposed that EHD2
Figure 5 Mutations in EHD2 impair association with caveolae and formation of large EHD2 complexes. (A) Domain structure of EHD2 with
generated point and deletion mutants and table summarizing effects of these mutations described in previous studies (Guilherme et al, 2004;
Daumke et al, 2007). (B) Confocal images of CV1 cells transiently expressing EGFP fusions of EHD2 mutants for 6–8h. Cells were ﬁxed and
stained for endogenous CAV1 (only shown for EHD2-I157Q–EGFPas the other mutants did not colocalize with CAV1). Scale bar 10mm. (C) Cell
lysates prepared from 3T3-L1 cells or HeLa cells expressing EHD2–EGFP were run through 10–40% sucrose velocity gradients and fractions
analysed by SDS–PAGE/western blot. In both cell lysates, EHD2 was present in distinct oligomeric species sedimenting at 8S, 60S, and 75S
(Hayer et al, 2010a). 3T3-L1 fractions were analysed with anti-EHD2 antibodies and HeLa fractions with anti-GFPantibodies. (D) EHD2 mutants
were analysed for their ability to form protein complexes with sedimentation coefﬁcients 460S. EGFP fusions of mutant proteins were
expressed for 6–12h in HeLa cells and lysates run through sucrose velocity gradients (as in C). Fractions were analysed with anti-EHD2
antibodies. Bars present mean±s.e.m. of relative EHD2 signal in fractions 9–12 (‘oligomeric EHD2’) from three independent experiments.
EHD2 conﬁnes caveolae to the plasma membrane
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(Daumke et al, 2007). To analyse the oligomeric state of
EHD2 proteins in cells, we prepared HeLa and 3T3L1 cell
lysates with Triton X-100 and subjected them to sucrose
velocity gradient centrifugation (Figure 5C). Western blot
analysis of the 14 fractions showed that most endogenous
and GFP-tagged EHD2 was present in a slowly sedimenting
peak in fractions 2–4. Since this corresponded to an MW of
66–200kDa (Hayer et al, 2010a), the peak probably contained
the EHD2 dimers (MW of EHD2: 61kDa). In addition, two
peaks containing about 30% of total EHD2 were observed
in fractions 9–12. This corresponded to complexes with
sedimentation coefﬁcients of 60 and 75S, which could
mean that they have a molecular weight of about 2.5 and
3.5MDa, respectively (Hayer et al, 2010a).
We have previously shown in similar gradients that CAV1
sediments as a large molecular weight complex of 70S (Hayer
et al, 2010a). To determine whether EHD2 was part of the
same complexes, we analysed cell lysates prepared using
octylglucoside (OG), a non-ionic detergent that dissociates
the CAV1 70S complex (Hayer et al, 2010a). As expected,
CAV1 was now exclusively in fractions 3–4 corresponding to
CAV1 8S complexes. However, EHD2 still sedimented as large
oligomers indicating that EHD2 oligomers were distinct from
the 70S CAV1 complex (Supplemenary Figure S5A). In addi-
tion, the EHD2 complexes were observed in MEF CAV1 / 
cells (Supplementary Figure S5B) showing that 60–75S EHD2
oligomers could form independently of caveolae.
Next, we tested the EHD2 mutants for their ability to form
high MW complexes. HeLa cells transiently expressing tagged
mutant proteins for 6–12h were lysed and analysed on
sucrose gradients. Mutations in the KPF/NPF motifs and
deletion of the EH domain were found to most dramatically
reduce oligomerization of EHD2 (Figure 5D; Supplementary
Figure S5C), suggesting that the KPF/NPF motifs and EH
domains were involved in 60–75S complex formation. This
observation provided support for a model that involves the
association of the EH domains of one dimer with KPF/NPF
motifs of an adjacent dimer thus generating a linear or curved
complex of EHD2 dimers as previously hypothesized
(Daumke et al, 2007). A signiﬁcant loss of high MW
complexes was also detected for the lipid-binding mutant
K327D, indicating that association with membranes and
especially negatively charged phospholipids was required
for oligomerization.
That the ATP-binding mutant (T72A) also was unable to
form oligomers indicated a central function for the G domain
(Figure 5D). Strikingly, the two other ATP-cycle mutants
(EHD2-T94A and EHD2-I157Q) permitted formation of high
MW complexes to the same extent as the wild-type protein
(Figure 5D; Supplementary Figure S5C). This indicated that
while ATP binding was necessary for oligomerization, ATP
hydrolysis was not. Interestingly, the mutants that were
unable to oligomerize all failed to associate with caveolae
suggesting that not only was membrane binding required for
oligomerization, but also oligomer formation was a prerequi-
site for caveolar association.
In combination with the localization data, our results
suggested that the EHD2 present in the cytosol is in the
dimeric form (Figure 1A). ATP binding allows the dimers to
associate with lipids in the PM via the positively charged
lipid-binding interface. Upon lipid binding, 60–75S EHD2
complexes are formed probably through interactions between
the EH domains and the KPF/NPF sequence in an adjacent
EHD2 dimer. As the ATP is hydrolysed, these complexes
interact and accumulate at caveolae. Although caveolae are
not needed for oligomerization, it is possible that oligomers
in cells containing caveolae actually form in association with
caveolae.
The ATPase domain regulates EHD2 dynamics and
function
Further studies were performed with EHD2-I157Q–EGFP,
which has an accelerated ATPase activity (Daumke et al,
2007), to elucidate the role of EHD2’s G domain. The
mutation in the P-loop of the G domain could either
stabilize the catalytic conformation and prevent exchange
of ADP to ATP (Li and Zhang, 2004), or impair the action of
potential nucleotide exchange factors facilitating ADP to ATP
exchange. FRAP experiments revealed that EHD2-I157Q–
EGFP failed to recycle after association with caveolae
(Figure 6A and B). This led us to express wild-type EHD2–
mCherry and EHD2-I157Q–EGFP together. The EHD-I157Q–
EGFP was now found trapped in caveolae with very little or
no wild-type EHD2 present (Figure 6C). In contrast to wild-
type EHD2, EHD2-I157Q was thus unable to dissociate result-
ing in the exclusion of wild-type EHD2. While ATP was
needed to dissociate EHD2 from caveolae, too rapid hydro-
lysis evidently prevented displacement of EHD2 from caveo-
lae. Consistent with a role for ATP in EHD2 dissociation from
caveolae, we found that after depletion of cellular ATP with
2-deoxyglucose and sodium azide for 40min, caveolae
remained decorated with EHD2–GFP (Figure 6D).
Strikingly, when EHD2-I157Q was expressed in CAV1 / 
cells, it showed a punctate distribution (Figure 6E). This was
in clear contrast to wild-type EHD2 that required the presence
of caveolae to form similar puncta (Figure 1C). When
CAV1 /  cells were transfected with EHD2-I157Q and
CAV1 together, the mutant EHD2 showed a punctate distribu-
tion that now perfectly overlapped with CAV1 signal
(Supplementary Figure S5D). These experiments suggested
that EHD2 puncta were assemblies of EHD2 complexes whose
formation depended on ATP hydrolysis. In the case of wild-
type EHD2, it seemed likely that association with caveolae
stimulated ATP hydrolysis and resulted in EHD2 enrichment
at caveolae. In contrast, the I157Q mutant with intrinsically
accelerated ATP-hydrolysis rate could form EHD2 puncta
independently of caveolae.
When EHD2-T72A–mCherry, the EHD2 mutant incapable
of binding ATP was overexpressed in HeLa cells stably
expressing CAV1–EGFP, we noticed that the amount of mo-
bile caveolae was signiﬁcantly enhanced (Figure 6F). The
phenotype was comparable to the impact of EHD2 knock-
down on CAV1 motility (Figure 2B). The result supported the
conclusion that EHD2 is involved in promoting mechanisms
that render caveolae in the PM stationary. To test whether the
mutant had a dominant-negative effect, we co-expressed
EHD2-T72A–mCherry and wild-type EHD2–EGFP in CV1
cells. Indeed, we found that wild-type EHD2 no longer
localized to caveolae (Figure 6G) indicating that the presence
of EHD2-T72A impaired wild-type EHD2 function. A possible
explanation was that mixed or mutant EHD2 dimers could not
form 60–75S complexes with mixed or mutant dimers, and
were thus defective in PM association and oligomer formation.
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showed that ATP binding was required for PM association
of EHD2 and for the formation of 60–75S complexes. The
ATP was hydrolysed when the 60–75S complexes associated
with caveolae. That the EHD2-I157Q mutant protein
with accelerated ATPase activity was unable to shuttle off
caveolae was presumably because it could not hold ATP for
long without hydrolysing it to ADP. Unlike wild-type
EHD2, it was able to form assemblies of several 60–75S
complexes in the absence of caveolae suggesting that
it did not require caveolae to activate ATP hydrolysis.
Moreover, EHD2-T72A, another mutant, acted as a
dominant-negative mutant and caused increased caveolar
motility.
Figure 6 The ATPase domain regulates EHD2 dynamics and function. (A) Representative confocal images of FRAP experiments with EHD2-
I157Q–EGFP expressing cells. No ﬂuorescence recovery at initially bleached spots can be detected during the recorded time. (B) FRAP curves of
EHD2–EGFP or EHD2-I157Q–EGFP-transfected CV1 cells (as in Figure 4D). Data points present mean values±s.e.m., n¼10 or 8 for EHD2–
EGFP or EHD2-I157Q–EGFP. (C) Representative confocal image of a CV1 cell co-expressing EHD2-I157Q–EGFP and EHD2–mCherry for 12h.
Cells were ﬁxed and stained for endogenous CAV1. Arrows in the magniﬁcation highlight EHD2-I157Q-positive spots that have weak/no EHD2
wild-type staining and colocalize with CAV1. (D) CV1 cells transfected with EHD2–EGFPand CAV1–mCherry were incubated for 40min in ATP-
depletion media and analysed by confocal microscopy. Magniﬁcation highlights colocalization of EHD2 and CAV1. (E) Confocal image of MEF
CAV1 /  cell transfected with EHD2-I157Q–EGFP for 6h. (F) Relative CAV1 ﬂuorescence 12min after bleaching peripheral regions in HeLa
cells, stably expressing CAV1–EGFP and transfected with mCherry control (n¼11) or EHD2-T72A–mCherry (n¼11) plasmids. Signiﬁcance of
mean differences between the conditions was calculated with a two-tailed unpaired t-test. ***P-valueo0.0001. (G) Representative confocal
image of a CV1 cell co-expressing EHD2–EGFP and EHD2-T72A–mCherry. Cells were ﬁxed and stained for endogenous CAV1. Arrows in the
magniﬁcation highlight that CAV1-positive spots are devoid of wild-type EHD2 and EHD2-T72A. All scale bars 10mm. (H) A model on the role
of oligomer formation and the ATP cycle in EHD2 association with caveolae and dynamic exchange. (1) Newly synthesized EHD2 dimers bind
ATPand are subsequently targeted to the plasma membrane via ionic interactions with negatively charged lipids. (2) Upon lipid binding, EHD2
dimers assemble into 60–75S oligomers via interactions of EH domain and KPF/NPF motifs in adjacent EHD2 dimers. (3) Association of EHD2
complexes with caveolae requires ATP hydrolysis, which may be stimulated at caveolae. (4) EHD2 proteins undergo dynamic exchange at
caveolae, which requires a new cycle of ATP binding and hydrolysis. EHD2 mediates a link to actin ﬁbres that run in close proximity to
caveolae.
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In many cell types, caveolae tend to be aligned along actin
ﬁlaments as shown for primary human ﬁbroblasts immunos-
tained for endogenous CAV1 and EHD2 (Figure 7A). When
cytochalasin D (CytoD) was added to disrupt the actin ﬁla-
ments, the stress ﬁbres rapidly disappeared and remaining
F-actin accumulated in patches. The distribution of caveolae
also changed; CAV1 now clustered around the F-actin aggre-
gates (Figure 7B). TIR-FM time-lapse movies of HeLa cells
expressing CAV1–EGFP and EHD2–mCherry allowed us to
follow the impact of CytoD-induced actin ﬁlament disruption
in live cells. They showed that after CytoD addition, the
majority of CAV1 and EHD2-containing puncta moved along
linear trajectories for distances of several microns, and came
to rest in clusters (Supplementary Movie S5). Movies made of
cells expressing RFP–actin and CAV1–EGFP conﬁrmed that
the caveolae were dragged along with the retracting actin in
the plane of the PM and that the clusters colocalized with
F-actin remnants (Figure 7C; Supplementary Movie S6). This
indicated that the caveolae were tethered to ﬁlamentous
actin.
The distribution and behaviour of caveolae was dramati-
cally altered when EHD2 was depleted by siRNA. Instead of
localizing in linear arrays along microﬁlaments, the CAV1-
containing spots were now evenly distributed in human
ﬁbroblasts (Figure 7A). Addition of CytoD caused the
Figure 7 EHD2 oligomers mediate a link of caveolae to F-actin. (A) Confocal images of primary human ﬁbroblasts immunostained with EHD2
and CAV1 antibodies and stained with ﬂuorescent Phalloidin to visualize ﬁlamentous actin. Cells were transfected with control siRNA or EHD2
siRNA. (B) Confocal images of human ﬁbroblasts transfected with control siRNA or EHD2 siRNA and treated for 5min with 5mM CytoD. CAV1
and Phalloidin signal is depicted. Side panels show enlargements of indicated regions in the merged images. Arrowheads highlight CAV1 close
to actin patches. (C) HeLa cells stably expressing CAV1–EGFP were treated with control siRNA or EHD2 siRNA and transfected with RFP–actin
(not depicted). Image depicts the CAV1–EGFP maximum intensity projection of all frames of a 7.5-min TIR-FM movie (90 frames, frame rate
0.2Hz, penetration depth 110nm) starting upon addition of 5mM CytoD. Distinct trajectories of caveolae moving in the PM plane due to actin
retraction can only be seen in control conditions. (D)C A V 1 /  cells were transfected with EHD2-I157Q–EGFPand RFP–actin (not depicted),
treated with CytoD and live imaged as in C.( D) Maximum intensity projection of EHD2-I157Q–EGFP signal reveals retracting puncta. (E)
Confocal images of CAV1 /  cells, transfected with EHD2-I157Q–EGFP, treated for 5min with 5mM CytoD and stained with ﬂuorescent
Phalloidin. Side panels show enlargements of indicated region in the merged image. Arrowheads highlight EHD2 close to actin patches. (F)
Confocal images of CAV1 /  cells, transfected with EHD2-T94A–EGFP, treated and analysed as in E. All scale bars 10mm.
EHD2 conﬁnes caveolae to the plasma membrane
M Stoeber et al
2359 &2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 10 | 2012redistribution of actin in the same way as in control cells, but
this failed to affect the distribution of CAV1. CAV1 continued
to be localized in discrete puncta randomly distributed over
the PM (Figure 7B). Consistently, actin ﬁlament disruption
with CytoD had little effect on caveolar distribution in EHD2
siRNA-treated HeLa cells expressing RFP–actin and CAV1–
EGFP imaged by TIR-FM (Figure 7C; Supplementary Movie
S7). The movies showed that CAV1 spots remained motile as
previously described (Figure 2). This indicated that the
tethering of caveolae to microﬁlaments depended on EHD2.
To determine whether EHD2 was itself able to associate
with F-actin and thus serve as a tether, we analysed MEF cells
devoid of CAV1. Experiments documented in Figure 1C had
already shown that when expressed in CAV1 /  cells wild-
type EHD2–EGFP did not form puncta nor did it align itself
with stress ﬁbres. However, it was also clear as shown in
Figure 6 that when the EHD2 mutant with accelerated
ATPase activity (EHD2-I157Q–EGFP) was expressed in the
CAV1 /  cells, the protein did form puncta and that the
majority of these puncta aligned themselves into linear arrays
(Figure 6E). After CytoD treatment, the linear arrays disap-
peared and the EHD2-I157Q spots retracted with F-actin and
accumulated in actin patches similarly to those observed for
CAV1 and wild-type EHD2 (Figure 7D and E; Supplementary
Movie S8). In contrast another mutant, the PM-associated
mutant EHD2-T94A–EGFP unable to hydrolyse ATP, showed
a diffuse PM localization and was not affected by CytoD
treatment (Figure 7F). Taken together, this showed that EHD2
complexes can link up with F-actin without being associated
with caveolae. However, for this to happen, the ATPase
activity has to be accelerated suggesting that the EHD2
needs to be in the ADP-bound form.
Discussion
Our results showed that EHD2 constitutes a major component
of invaginated caveolae and caveolar clusters. It is recruited
from the cytosol to the PM, and present as large 60–75S
complexes, the formation of which requires ATP binding and
membrane association. The EHD2 complexes are responsible
for tethering caveolae to actin ﬁlaments and preventing their
lateral movement and the formation of caveolar vesicles.
Unlike CAV1 and the cavins, which are stable components
of caveolae, EHD2 undergoes a continuous turnover driven
by the binding and hydrolysis of ATP.
The majority of caveolae in the PM are static (Thomsen
et al, 2002; van Deurs et al, 2003; Kirkham et al, 2005;
Pelkmans and Zerial, 2005; Tagawa et al, 2005). Integrin
expression, insulin activation, and the addition of
phosphatase inhibitors, gangliosides or SV40 are known to
activate caveolae and induce the generation of mobile,
endocytic caveolar vesicles (Parton et al, 1994; Pelkmans
et al, 2002; Kirkham and Parton, 2005; Sharma et al, 2005;
Parton and Simons, 2007; Botos et al, 2008; Lajoie and Nabi,
2010; Singh et al, 2010). We found that depletion of EHD2 by
RNAi and expression of a dominant-negative EHD2 mutant
signiﬁcantly elevated the fraction of mobile caveolae without
external stimuli. Since the caveolar vesicles formed contained
cavin-1 and their formation was dependent on dynamin, they
were likely to be derived from the PM.
Consistent with a constraining role, we found that when
EHD2 was overexpressed the endocytic function of caveolae
was suppressed. We followed CT-B a ligand known to be
internalized via caveolae when added at low concentrations
(Parton, 1994; Pelkmans et al, 2004). It accumulated in
EHD2-positive caveolae in the PM, and delivery to the
Golgi complex was decreased. A similar reduction in
Golgi-localized CT-B signal after overexpressing EHD2 was
recently reported by Benjamin et al (2011).
In cells, EHD2 occurred in different oligomeric forms.
The majority was present in a slowly sedimenting form that
most likely corresponded to soluble homo-dimers (Figure 1A;
Daumke et al, 2007). This was the only form observed when
lipid or ATP binding was compromised through point
mutations in the respective domains. About 30% of EHD2
sedimented as complexes of 60 and 75S with estimated
molecular weights in the 2.5–3.5MDa range. Since efﬁcient
formation of these large complexes required a functional
lipid-binding domain, they were probably membrane asso-
ciated. Experiments with mutants indicated furthermore that
the formation of these complexes required, in addition to
lipid and ATP, a functional EH domain, and intact KPF/NPF
motifs to which EH domains speciﬁcally bind.
In-vitro experiments by Daumke et al (2007) have shown
that in the presence of ATP and liposomes containing acidic
phospholipids, isolated EHD2 oligomerizes to form circular,
liposome-associated assemblies with about 20 dimers. These
have a calculated molecular weight similarly to the estimated
weight of the complexes that we observed in cell extracts.
Daumke et al (2007) hypothesized that the EH domains of
one dimer interact with the KPF/NPF motifs of neighbouring
dimers resulting in the generation of a linear complex. Given
the similarities in size and assembly requirements, it is likely
that the 60 and/or 75S complexes observed in cells are
equivalent to the complexes observed in vitro. In other
words, the 60 and 75S complexes may represent linear or
circular assemblies of EHD2 attached to the head groups of
negatively charged lipids such as phosphatidylserine in the
inner leaﬂet of the PM.
The architecture of caveolar domains is remarkably in that
the major protein components all exist as large, oligomeric
complexes. We have shown previously that CAV1 and the
cavins are present as independent assemblies with sedimen-
tation coefﬁcients in the 60–70S range (Hayer et al, 2010a).
Like the EHD2, the cavins are peripheral membrane proteins
recruited from the cytosol (Bastiani et al, 2009; Hayer et al,
2010a). Both EHD2 and the cavins have afﬁnity for negatively
charged phospholipids and the formation of complexes is
independent of CAV1 (Blume et al, 2007; Daumke et al, 2007;
Hill et al, 2008; Bastiani et al, 2009; Hayer et al, 2010a). Their
afﬁnity for caveolar domains may be explained by the
postulated enrichment of phospatidylserine induced by
CAV1 (Pike et al, 2002; Wanaski et al, 2003).
Using mutants of EHD2, we found that the formation of the
60–75S complexes was not sufﬁcient for association with
caveolae. The ATPase activity was also needed. It remains
to be determined whether the hydrolysis of ATP is required to
induce interactions between 60 and 75S complexes or to
promote association with other structures in caveolar do-
mains. However, it was apparent that multiple 60–75S com-
plexes were recruited to each caveolae because only after
caveolar association was ﬂuorescent EHD2 detectable as
deﬁned spots. It is interesting in this context that the I157Q
mutant of EHD2 with accelerated ATPase activity was able to
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and to associate with actin ﬁlaments in the absence of
caveolae. This could imply that association with the caveolar
domain somehow increases the ATPase activity of wild-type
EHD2 complexes and promotes mulitmerization and actin
binding. In-vitro experiments have shown that the ATPase
activity can be accelerated by addition of negatively charged
lipids (Daumke et al, 2007).
The existence of an interaction between the actin cytoske-
leton and caveolae has been proposed in several morpholo-
gical studies. These show microﬁlaments in close proximity
to caveolae, and one of the studies identiﬁes crossbridges
between caveolae and actin ﬁbres (Rothberg et al, 1992;
Richter et al, 2008). The actin cytoskeleton is also known
to affect caveolae at the functional level. On the one hand, it
is thought that it controls internalization by conﬁning
caveolae to the PM. On the other hand, actin is thought to
promote efﬁcient caveolar internalization after stimulation
(Parton et al, 1994; Stahlhut and van Deurs, 2000; Mundy
et al, 2002; Pelkmans et al, 2002; Sverdlov et al, 2009).
Our results were consistent with the existence of an
intimate connection between stationary caveolae and the
actin cytoskeleton. Using CytoD to collapse the microﬁlament
network, we could show in live cells that the EHD2-contain-
ing caveolae moved together with the collapsing ﬁbres.
EHD2 depletion resulted in a loss of this connection; most
of the caveolae now showed increased motility and
failed to be dragged along by the collapsing microﬁlaments.
EHD2 was probably itself part of the structure that formed the
physical link between caveolae and actin ﬁlaments. This
was suggested by an EHD2 mutant that possessed an elevated
ATP hydrolysis rate. Unlike wild-type EHD2, it formed actin-
associated puncta even in the absence of caveolae.
The attachment of EHD2 with caveolae was not permanent
as observed for CAV1 and the cavins. FRAP experiments
showed that the EHD2 was dynamically associated with
caveolae and underwent turnover. The half-life was about
2–4min, and the presence of ATP was required. Although
relatively slow, this turnover is probably signiﬁcant because
it may allow adjustment and ﬁne-tuning of caveolar dy-
namics.
Taken together, our results demonstrated that EHD2 is a
critical factor in regulating the dynamic behaviour of caveo-
lae and deﬁning their role in clathrin-independent endocyto-
sis. A concomitant study conﬁrms the importance of EHD2 in
constraining caveolae to the PM (Moren et al, 2012). The
authors ﬁnd that EHD2 speciﬁcally associates with caveolae
at the cell surface. Upon EHD2 depletion, they detect an
increased amount of dynamin-dependent caveolar budding.
We further showed that when EHD2 complexes associate
with caveolae in the PM, they decrease caveolar motility,
increase clustering, and suppress formation of caveolar
vesicles by mediating an immobilizing link to the actin
cortex. This conﬁnement regimen can evidently be reversed
by external stimuli that allow endocytosis to occur. It is likely
that in promoting the link, EHD2 interacts with other cellular
proteins. Possible interaction partners are EHBP1 shown to
bind EHD2 and colocalize with F-actin (Guilherme et al,
2004), the actin crosslinking protein ﬁlamin A described as
a linker between caveolae and actin in caveolar anchorage
and internalization (Sverdlov et al, 2009; Muriel et al, 2011),
and other cytoskeletal proteins identiﬁed at the neck of
caveolae (Foti et al, 2007). It is possible that EHD2 has
other functions such as preventing the action of the
membrane scission factor dynamin-2 (Jakobsson et al,
2011). While EHD2 seems to be speciﬁcally responsible for
caveolar conﬁnement, it remains unclear which factors
regulate the release of EHD2 proteins from caveolae to
allow caveolar scission and internalization.
Materials and methods
Cell culture and transfections
CV1 (ATCC), HeLa (ATCC), normal human primary dermal ﬁbro-
blasts (ATCC), and CAV1–/– MEFs (Drab et al, 2001) were grown in
DMEM (Invitrogen), supplemented with 10% FCS and 1% glutamax
(Invitrogen). HeLa-CAV1–EGFP or HeLa-cavin-1–EGFP were grown
as HeLa, but in the presence of 0.5mg/ml G418 or 0.5mg/ml
puromycin. 3T3-L1 pre-adipocytes (ATCC) were grown in DMEM
(Invitrogen), supplemented with 10% bovine serum and 1%
glutamax (Invitrogen). CV1, HeLa, and CAV1 /  cells were
transfected by electroporation (AMAXA) or using Lipofectamine
2000 (Invitrogen) according to manufacturer’s recommendations.
Plasmids
For EHD2–mEGFP and EHD2–mCherry, human EHD2 cDNA from
an ORFeome collection (V3.1 Open Biosystems) was cloned into
pmEGFP-N-DESTor pmCherry-N-DEST destination vectors carrying
a Gateway cassette. QuikChange site directed mutagenesis
(Stratagene) was used to obtain point mutants (T72A, T94A,
I159Q, and K327D). The KPF/NPF (F122A/F128A) mutant was
generated by sequential mutagenesis. The EHD2–mCherry rescue
plasmid was generated by silently mutating two nucleotides in the
region targeted by EHD2 siRNA SI04205271 with QuikChange PCR.
EHD2-DEH was acquired by PCR of EHD2 amino acids 1–448.
Dynamin2-K44A-mRFP (splice variant IIA) was derived from
Dyn2-K44A-GFP generously provided by Mark A McNiven by
exchanging GFP with mRFP. Cavin-3–EGFP was generated by PCR
amplifying human cavin-3 and cloning into a pIRESpuro-EGFP
vector. EHD1, EHD3, and EHD4 were a kind gift of Manju George
(George et al, 2007). Other constructs have previously been
described: CAV1–mEGFP, CAV1–mCherry, CAV1–HA, Flot1–EGFP,
Flot2-EGFP, cavin-1–mEGFP, cavin-1–mCherry, cavin-2–EGFP
(Hayer et al, 2010a), Rab5–EGFP (Hayer et al, 2010b), and
CLC-GFP (Tagawa et al, 2005).
RNAi
The siRNA oligomers targeting EHD2 (SI04205271 and SI04315108)
were purchased from QIAGEN and transfected into HeLa, human
ﬁbroblast, HeLa-CAV1–EGFP, or HeLa-cavin-1–EGFP at 15nM using
Lipofectamine RNAiMAX (Invitrogen) according to manufacturer’s
recommendations. Non-targeting siRNA (AllStarsNeg; QIAGEN) was
used as control siRNA. Cells were analysed 60–72h after transfection.
Antibodies and other reagents
Rabbit pAb anti-CAV1 was from Santa Cruz (N20, sc-894), rabbit
pAb anti-cavin-1 from Abcam (ab48824), mouse mAb anti-GFP
from Living Colours (JL-8), rabbit pAb anti-EHD2 from Santa
Cruz (sc-100724, used for WB), goat pAb anti-EHD2 from Abcam
(ab23935, used for IF), rabbit pAb anti-giantin from Covance (PRB-
114C), and mAb anti-b-actin (A1978) was from Sigma. Alexa Fluor-
conjugated secondary antibodies for immunoﬂuorescence were
from Invitrogen.
For disruption of F-actin, cells were incubated with 5mM
Cytochalasin D. For ATP depletion, cells were washed and incubated
in glucose-free media with 10mM 2-deoxy-D-glucose and 10mM
sodium azide. All chemicals were purchased from Sigma-Aldrich.
Immunoﬂuorescence imaging and analysis
Cells grown on coverslips were ﬁxed using 4% formaldehyde in
PBS. Cells were permeabilized using 0.05% saponin and 1% BSA in
PBS and incubated with the appropriate primary (1:500) and
secondary (1:1000) antibodies, and coverslips were mounted on
slides using Immu-Mount (Thermo Scientiﬁc). Imaging was per-
formed on an inverted confocal microscope system (LSM 510 Meta;
Carl Zeiss, Inc.). Colocalization of CAV1 spots with proteins of
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CAV1 channel. Coordinates of caveolar spots were extracted with
the ‘analyse particles’ function and checked for colocalization with
protein of interest.
Fluorescence recovery after photobleaching
For FRAP experiments that quantiﬁed caveolar movement, either
HeLa-CAV1–mEGFP cells or HeLa-cavin-1–EGFP cells were treated
with siRNA for 60–72h. On the day prior to acquisition, cells were
plated on 18mm coverslips. For FRAP experiments that quantiﬁed
recovery of cavins or EHD2 at stationary caveolae, EGFP-tagged
cavins or EHD2 together with CAV1–mCherry were expressed in
CV1 cells for 14h. FRAP experiments were performed at 371Co na n
inverted confocal microscope system (LSM 510 Meta) equipped with
a temperature-controlled stage and a  100 1.4 NA objective with
2  zoom as described previously (Tagawa et al, 2005). A deﬁned
region was bleached at 100% laser transmission for 25 iterations
using the 488-nm line from a 30-mWArgon laser and ﬂuorescence
recovery was monitored by scanning a deﬁned region at low laser
transmission (50% power, 3% transmission) every 20s for 30
frames. Images were acquired as 12-bit LSM ﬁles at 512 512
pixels/frame and 0.14mm/pixel lateral resolution. Image series
with little or no apparent motion of cells were quantiﬁed with
ImageJ. The mean ﬂuorescence intensity of the bleached region at
each time point was corrected for background signal and
photobleaching of the cell as in Tagawa et al (2005). Fluorescence
intensity before bleaching was normalized to 100% and directly
after bleaching to 0%. For FRAP experiments of cavins and EHD2 at
stationary caveolae, an image of CAV1–mCherry was recorded
before and after the image series to assure that anchored caveolae
had not moved in the recorded time.
Fluorescence resonance energy transfer
FRET efﬁciency was determined by performing acceptor photo-
bleaching with subsequent measurement of donor dequenching
with the ﬂuorophore pairs EGFP (donor) and mCherry (acceptor).
Cells in 8-well Labtek chambers (Thermo Scientiﬁc) were transi-
ently transfected (Lipofectamine 2000) with ﬂuorescent fusion
proteins and expression allowed for 14h. Cells were ﬁxed with
4% methanol-free formaldehyde (Thermo Scientiﬁc) and subse-
quently imaged in PBS. FRET analysis was performed using a
Leica SP2-FCS microscope. EGFP was excited with 20% 488nm
laser intensity and emission was detected at 505–550nm. mCherry
was excited with 20% 561nm laser intensity and emission detected
at 610–685nm. Images were taken with  63 1.4 NA DIC, Oil, HCX
Plan-Apo objective, 3  zoom and a pinhole of one airy unit with
focus on the PM. Bleaching was performed with 100%
561nm intensity and 20 iterations. Images were analysed using
the Leica LCS Imaging software. To determine FRET efﬁciency,
donor ﬂuorescence intensity before (Dpre) and after (Dpost) photo-
bleaching was measured in membrane spots (¼region of interest
(ROI)) within the bleached and non-bleached region for each cell
and the background subtracted. FRET efﬁciency was calculated for
every ROI of the imaged cell according to the formula:
(Dpost Dpre)/Dpost 100. For statistical analysis, the mean FRET
efﬁciency in ROIs within bleached and non-bleached regions was
determined for every cell and signiﬁcance between means analysed
with a two-tailed paired t-test.
CT-B uptake
CV1 cells were transfected with EHD2–mCherry using AMAXA,
seeded onto glass coverslips and expression allowed for 14h. Cells
were incubated at 371C with 50ng/ml Alexa Fluor 488-labelled CT-B
(Molecular Probes). After 30min, cells were washed 3  followed by
a 30-min chase at 371C, washed and ﬁxed for 20min in 4% FA in PBS.
Subsequently, cells were stained for Giantin or CAV1 and imaged with
confocal microscopy. For quantiﬁcation of CT-B signal in the Golgi
region, a custom-made ImageJ based software was used to deﬁne the
Golgi region, to measure the mean intensity of CT-B-488 signal in
these areas and to subsequently score cells for being EHD2-mCherry
positive or negative in each image. Localization of CT-B in caveolar
spots after the 30-min chase was analysed with ImageJ using thresh-
olding and particle analysis to obtain coordinates of CAV1 or
CAV1þEHD2-mCherry-positive puncta that were subsequently
checked for colocalization with CT-B-488.
Live-cell ﬂuorescence imaging
CV1 cells expressing ﬂuorescently tagged constructs and seeded
onto 18mm coverslips were transferred to a custom-built metal
microscope coverslip chamber in CO2-independent medium
(Invitrogen), supplemented with 10% FCS. A Leica AM TIRF system
was used, equipped with a  100 1.47 NA objective, an Andor iXon
EM-CCD camera and a temperature-controlled stage. The depth of
the evanescent ﬁeld was adjusted to the indicated penetration
depth. EGFP and mCherry channels were acquired sequentially.
Image sequences were analysed by ImageJ.
Immuno-EM
EHD2–EGFP and CAV1–HA were expressed in CV1 cells for 6h.
Cells were ﬁxed in 4% formaldehyde and 0.1% glutaraldehyde in
1  PHEM buffer for 90min (Schliwa et al, 1981). Cryo-sectioning
and immunolabelling were performed as described elsewhere
(Tokuyasu, 1973). In brief, ultrathin sections (50–70nm) from
gelatin-embedded and frozen cell pellets were obtained using an
FC7/UC7-ultramicrotome (Leica, Vienna, Austria). Immunogold
labelling was carried out on thawed sections with anti-GFP
(Rockland, 600-101-215) and anti-HA (Covance, HA-11) antibodies
and 10 or 5nm protein A-gold (UMC Utrecht University, Utrecht,
Netherlands) (1:50). Sections were examined with a CM10 Philips
transmission electron microscope with an Olympus ‘Veleta’ 2kx2k
side-mounted TEM CCD camera. For colocalization analysis, the
cryo-sections were followed in a meandering pattern. Screening
along the PM, visible colocalization events of 5 and 10nm gold
particles were counted and scored as caveolae or non-caveolae
structure based on invaginated morphology in four independent
scans, each counting 4200 gold particles. To determine the distance
of EHD2 and CAV1 gold particles from the PM, perpendicular
measurements towards the PM were performed from 10 or 5nm
gold particles within a maximal distance of 300nm from the
membrane.
Velocity gradient centrifugation
Sucrose velocity gradient centrifugation was performed as described
previously (Hayer et al, 2010a). Cells were lysed for 20min at room
temperature in 0.5% Triton X-100 (TX100) or (if speciﬁcally
indicated) in 60mM OG in TNE (20mM Tris–HCl, HpH 7.4,
100mM NaCl, and 5mM EDTA) supplemented with Complete
protease inhibitor cocktail (Roche). Postnuclear supernatants
were loaded onto 10–40% linear sucrose gradients prepared in
0.15% TX100/TNE or 35mM OG/TNE and spun in a rotor
(SW55Ti; Beckman Coulter) at 50000r.p.m. (237020g)a t4 1C for
255min. Gradient fractions were analysed by SDS–PAGE/western
blotting.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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